Results 161 to 170 of about 1,700,231 (391)

Primary renal pelvis and ureter squamous cell carcinoma (SCC): a rare case report and review of literature

open access: yesInternational Medical Case Reports Journal, 2019
Mehdi Salehipour,1 Niloofar Dastgheib,2 Masood Hosseinzadeh,3 Alireza Makarem,1 Alireza Rezvani,4 Alireza Sanati,1 Sona Tayebi11Department of Urology, Shiraz University of Medical Sciences, Shiraz, Iran; 2Student Research Committee, Shiraz University of ...
Salehipour M   +6 more
doaj  

Comparative histopathology of gonadal neoplasms in marine bivalve mollusks

open access: bronze, 1994
Esther C. Peters   +3 more
openalex   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

open access: yesMolecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert   +13 more
wiley   +1 more source

A Rare Case of Myoepithelioma around the Left Orbit

open access: yesJournal of Dental Research, Dental Clinics, Dental Prospects, 2011
Myoepithelioma is a rare neoplasm of the salivary glands, generally occurring in the parotid gland and less often in the minor accessory salivary glands of the oral cavity.
Kapila Rishabh   +2 more
doaj  

THYMIC NEOPLASMS

open access: yesJournal of Thoracic Surgery, 1956
D B, EFFLER, L J, MCCORMACK
openaire   +2 more sources

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

open access: yesMolecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser   +14 more
wiley   +1 more source

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

open access: yesMolecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy